Ann: CEO presentation to Broker Meets Biotech - Perth, page-15

G'day Ajostu, Great to see you interested in this company. I firmly believe that it is the best and most clear cut risk/reward situation that I have come across thus far. I don't think you have missed anything. To me placebo effect is the only (small) risk.

As you quite rightly point out, the placebo IS the standard treatment. I had not thought of this fact previously. Whether this is significant or not I can't decide, although I could (but won't) go into a rather convoluted argument to suggest that it may be.

I am as confident as I will allow myself to be that by the end of Nov this company will have erased the (hopefully short termish) disappointment of the NEU situation.

If you decide to jump in I will look forward to any contributions that you make here. From experience they are invariably considered and relevant.